| SpectraBase Spectrum ID |
8H877TqsobI |
| Name |
1,4-Di-(4-bromobenzyl)piperazine |
| Classification |
Piperazine designer drug |
| Copyright |
Copyright © 2024 DigiLab GmbH and Wiley-VCH GmbH. All Rights Reserved. |
| Exact Mass |
421.999324652 u |
| Formula |
C18H20Br2N2 |
| InChI |
InChI=1S/C18H20Br2N2/c19-17-5-1-15(2-6-17)13-21-9-11-22(12-10-21)14-16-3-7-18(20)8-4-16/h1-8H,9-14H2 |
| InChIKey |
UGUVREVSQRRARY-UHFFFAOYSA-N |
| Ionization Type |
Electron Ionization (EI) |
| Molecular Weight |
424.180 g/mol |
| Nominal Mass |
422 u |
| Quality |
960 |
| Retention Index |
2837 |
| SMILES |
C1N(CCN(C1)CC=1C=CC(=CC1)Br)CC1=CC=C(C=C1)Br |
| SPLASH |
splash10-0l6s-3960000000-5718c091296b8d2748ac |
| Source of Spectrum |
DigiLab GmbH (C) 2024 |
| Synonyms |
Piperazine,1,4-di-(4-bromobenzyl)
1,4-bis(4-bromobenzyl)piperazine |
| Technique |
GC/MS |
| Wiley ID |
DD2024_011136 |
